Urologia

Diretriz AUA | Diagnóstico e tratamento de cistite intersticial/síndrome da bexiga dolorosa.

16 Mai, 2022 | 16:32h

Diagnosis and Treatment Interstitial Cystitis/Bladder Pain Syndrome (2022) – American Urological Association

Revisão | Avaliação e tratamento da função cognitiva de pacientes com câncer de próstata tratados com inibidores do receptor androgênico de segunda geração.

12 Mai, 2022 | 14:18h

Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors – CNS Drugs

Estudo randomizado | Reloxaliase vs. placebo na hiperoxalúria entérica.

10 Mai, 2022 | 14:14h

Randomized Placebo-Controlled Trial of Reloxaliase in Enteric Hyperoxaluria – NEJM Evidence

Comentário no Twitter

Patients with enteric hyperoxaluria received reloxaliase, an enzyme that degrades oxalate in the GI tract, or placebo with food for 4 weeks. There was a greater reduction in urinary oxalate excretion with reloxaliase. https://t.co/x7m12QHyWX #NephTwitter #UroSoMe #ClinicalTrials pic.twitter.com/rzCpd6YfLM

— NEJM Evidence (@NEJMEvidence) May 6, 2022

Revisão | Abordagem global para melhorar o cuidado no câncer peniano.

6 Mai, 2022 | 17:20h

A global approach to improving penile cancer care – Nature Reviews Urology (se o acesso a este link for pago, tente este)

Diretriz | Tratamento de pequenas massas renais.

29 Abr, 2022 | 15:08h

Canadian Urological Association guideline: Management of small renal masses – Canadian Urological Association Journal

Ver também: Summary of Recommendations

Revisão | Teste germinativo e aconselhamento genético no câncer de próstata.

29 Abr, 2022 | 14:55h

Germline testing and genetic counselling in prostate cancer – Nature Reviews Urology (se o acesso a este link for pago, tente este no PMC)

Podcast | Sintomas em trato urinário inferior, hiperplasia prostática benigna e incontinência urinária.

29 Abr, 2022 | 14:43h

LUTS, BPH, and Urinary Incontinence Triple Distilled – The Curbsiders

M-A | Intensificação da terapia sistêmica em adição a tratamento local definitivo no câncer de próstata não metastático desfavorável.

27 Abr, 2022 | 16:16h

Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis – European Urology

Diretriz de consenso | Tratamento de pacientes com câncer de próstata avançado.

27 Abr, 2022 | 15:35h

Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021 – European Urology

Comentário no Twitter

Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021https://t.co/GjTGPx8IbN @APCCC_Lugano @Silke_Gillessen @AOmlin @AarmstrongDuke @piet_ost @Prof_IanD @DrSpratticus @charlesryanmd @Tilki_De @declangmurphy pic.twitter.com/FU0Fbjf8WZ

— European Urology (@EUplatinum) April 22, 2022

Estudo observacional sugere que a coprescrição de inibidores da fosfodiesterase tipo 5 (p. e., sildenafila) e nitratos orais não está associada a risco aumentado de desfechos cardiovasculares adversos em homens com doença cardíaca isquêmica.

21 Abr, 2022 | 12:39h

Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease: A Case-Crossover Study – Annals of Internal Medicine

Comentários:

PDE5 inhibitors didn’t increase cardiovascular events in men on nitrates for heart disease – ACP Internist

PDE5 Inhibitors Prescribed for Men on Oral Nitrates for IHD – HealthDay